… be contained when an efficient therapy or vaccine will become available. This … SARS-CoV-2,
the pathophysiology of the infection, the treatments currently tested, and vaccines developed…

… acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which is currently greatly … or
vaccines to fight SARS-CoV-2. In this review, we present a detailed perspective of SARS-CoV-2, …

… protein which is main antigenic target of 3 SARS-CoV-2 vaccines that have been licensed in
… the drug development against SARS-COV-2 rather than whole focus on the vaccines. Such …

… infected with SARS-CoV-2 did not develop reinfection following … As it is known that
SARS-CoV-2 infects target cells through … of SARS-CoV-2, around 15 potential vaccine candidates …

… treatment, patient management, and vaccine designs is based … to develop a promising “complete”
peptide vaccine using its Ii… -SARS-CoV-2 peptide epitopes, which contain target amino …

… in virology, epidemiology, and clinical management … way to facilitate the development of
vaccines against SARS-CoV-2. … that directly target SARS-CoV-2 will be most effective. Besides, …

… are potential targets for designing subunit vaccines against SARS-CoV-2 infection. … intranasal
vaccines that are being developed against SARS-CoV-2, and their clinical developmental …

… in SARS-CoV-2 vaccine development, up to date the last inactivated vaccine international
clinical … virus species to be used as a target antigen for SARS-CoV-2 vaccine development 68 . …

… targeted by therapeutic agents for treatment of SARS-CoV-2 as discussed above. The current
management of … This provides a platform to develop anti-SARS-CoV-2 drugs that target the …

… of the SARS-CoV-2 genome initiated a global program to develop vaccines as well as to …
therapeutic efficacy against SARS-CoV-2, considerable attention has been focused on re-…